Lisa Y. Foo - 29 Jul 2026 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Reporting relationship: EVP, Chief Operating Officer
Issuer ticker: THC
Reported as of: 29 Jul 2026
Net transaction value: -$2,580,300
SEC form: 4
Accepted by SEC: 31 Jul 2026, 20:00:03 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo

Key filing fact

Lisa Y. Foo filed Form 4 for TENET HEALTHCARE CORP (THC) on 31 Jul 2026.

Key facts

This page summarizes Lisa Y. Foo's Form 4 filing for TENET HEALTHCARE CORP (THC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 31 Jul 2026, 20:00.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: -$2,580,300.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001916153 Primary reporting owner

Foo Lisa Y

Relationship: EVP, Chief Operating Officer
Address: 14201 DALLAS PARKWAY, DALLAS
Signature: Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo
Signature date: 31 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

THC transaction

Common Stock

Sale

Transaction value: $2,580,300
Shares: -10,000
Change %: -24%
Price: $258.03
Shares after: 32,053
Date: 29 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $257.97 to $258.43. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.